可测量/最小残留疾病:什么方法和什么截止点?
1Haematological Malignancy Diagnostic Service (HMDS), Level 3, Bexley Wing, St James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK; Department of Epidemiology and Cancer Statistics (ECSG), University of York, Seebohm Rowntree Building, York, YO10 5DD, UK.
最少残留疾病 (MRD) 测试对于评估时间有限的癌症治疗至关重要. 这一审查指导了选择合适的MRD方法和临床使用门.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床诊断 临床诊断 临床诊断
背景情况:
- 最少残留疾病 (MRD) 测试是临床试验中的关键生物标志物,用于限时治疗.
- 在各种癌症中,越来越多地评估MRD引导的治疗策略.
研究的目的:
- 为了比较当前MRD测试方法的技术和实践方面.
- 为不同的临床情景提供选择最佳MRD方法和值的指导.
主要方法:
- 审查和比较现有的MRD检测技术.
- 对在临床环境中实施的实际考虑的分析.
主要成果:
- 详细介绍了不同MRD测定的主要技术特征.
- 讨论了选择方法的实际考虑.
结论:
- 适当选择MRD方法和值对于有效的临床应用至关重要.
- 提供了指导,以帮助临床医生为患者选择最佳的MRD策略.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
06:55Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
相关概念视频
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Kaplan-Meier Approach
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.
